Please wait a minute...
转化医学研究
“中国核心期刊(遴选)数据库”收录期刊
“万方数据—数字化期刊群”全文入网期刊
“中国学术期刊网络出版总库”及CNKI系列数据库收录期刊
“中文科技期刊数据库”收录期刊
转化医学研究  2011, Vol. 1 Issue (1): 69-79
  综述 本期目录
Demands and challenges to the personal medicine of cancer research
Dan Li,Qi-min Zhan*
State Key Laboratory of Molecular Oncology, Cancer Institute, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China
Demands and challenges to the personal medicine of cancer research
 全文: PDF(5556 KB)  
摘要:Personalized medicine is defined as “a form of medicine that uses information about a person's genes, proteins, and environment to prevent, diagnose, and treat disease” by the U.S. National Cancer Institute. The applications of personalized medicine in cancer is broad, including: evaluating the risk of developing a particular type of cancer and selecting screening strategies to lower this risk; Matching the right patients with the appropriate treatments that are more likely to be effective and reducing side effects by targeting treatment to each individual patient; Predicting the risk of recurrence and providing strategies to identify the patients who would benefit from adjuvant therapy. With the help of advanced knowledge of molecular oncology and development of new technologies, such as whole genome sequencing, SNPs analysis, DNA-microarray technology, proteomics by mass spectrometry and bioinformatics, patients may receive more effective tailored therapy that targeting the specific tumor. Although many challenges still remain, it is clear that personalized medicine will dramatically change the cancer therapy in the near future.
出版日期: 2012-05-23
 引用本文:   
Dan Li,Qi-min Zhan*. Demands and challenges to the personal medicine of cancer research[J]. 转化医学研究, 2011, 1(1): 69-79.
 链接本文:  
https://academic.hep.com.cn/tmr/CN/Y2011/V1/I1/69
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed